1,2-benzisothiazol-3-one derivatives as a novel class of small-molecule caspase-3 inhibitors

Bioorg Med Chem. 2014 Apr 15;22(8):2416-26. doi: 10.1016/j.bmc.2014.03.002. Epub 2014 Mar 12.

Abstract

A novel series of 1,2-benzisothiazol-3-one derivatives was synthesized and their biological activities were evaluated for inhibiting caspase-3 and -7 activities, in which some of them showed low nanomolar potency against caspase-3 in vitro and significant protection against apoptosis in a camptothecin-induced Jurkat T cells system. Among the tested compounds, compound 5i exhibited the most potent caspase-3 inhibitory activity (IC50=1.15 nM). The molecular docking predicted the interactions and binding modes of the synthesized inhibitor in the caspase-3 active site.

Keywords: 1,2-Benzisothiazol-3-one; Apoptosis; Caspase-3; Inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Benzothiazoles / chemical synthesis
  • Benzothiazoles / chemistry*
  • Benzothiazoles / pharmacology
  • Binding Sites
  • Camptothecin / toxicity
  • Caspase 3 / chemistry*
  • Caspase 3 / metabolism
  • Caspase Inhibitors / chemical synthesis
  • Caspase Inhibitors / chemistry*
  • Caspase Inhibitors / pharmacology
  • Catalytic Domain
  • Humans
  • Jurkat Cells
  • Molecular Docking Simulation
  • Morpholines / chemical synthesis
  • Morpholines / chemistry*
  • Morpholines / pharmacology
  • Static Electricity
  • Thiazoles / chemical synthesis
  • Thiazoles / chemistry*
  • Thiazoles / pharmacology

Substances

  • Benzothiazoles
  • Caspase Inhibitors
  • Morpholines
  • N-(4-morpholinophenyl)-3-oxobenzo(d)isothiazole-2(3H)-carboxamide
  • Thiazoles
  • Caspase 3
  • 1,2-benzisothiazoline-3-one
  • Camptothecin